Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches -- Ignore unavailable to you. Want to Upgrade?

To: w0z who wrote (32784)	10/3/2017 9:45:42 PM
From: i-node	Read Replies (1) \| Respond to of 39297

This is what the hospital says on its website. (below) I'm thinking WTH. MAYBE they insist on doing a biopsy before letting you get the MRI. What kind of sense does that make? I have no idea if my insurance will cover it outside of Arkansas. What a mess. UroNav MR/Ultrasound (US) fusion is a new option for patients with negative transrectal ultrasound-guided (TRUS) biopsy. This new technique fuses pre-biopsy magnetic resonance images of the prostate with ultrasound-guided biopsy images in real time, for excellent delineation of the prostate and suspicious lesions. Performing biopsy with MR/US fusion holds the potential to target the suspicious areas, reduce the number of tissue samples acquired and may reduce the risk of infection, bleeding, pain and recovery time. Candidates for MR/US fusion have:an elevated prostate-specific antigen (PSA) level greater than foura negative prior transrectal ultrasound-guided biopsy with continued elevation or rising PSAa positive digital rectal examination with negative transrectal ultrasound-guided biopsy